exenatide vs tirzepatide Semaglutide Tirzepatide: Which GLP-1 Wins for Weight Loss? Comparison of the GIP a

2023 May ;22(5):1647-1657

Published safety and tolerability findings Published clinical studies on Tirzepatide indicate that the most commonly reported adverse events are gastrointestinal, especially nausea, diarrhoea, decreased appetite, vomiting and constipation

B12 is especially beneficial for individuals who have difficulty absorbing B12 from food or oral supplements, which can occur due to certain digestive disorders, age-related changes, or specific medical conditions

A significant increase in the pharmacokinetic parameters of glimepiride such as AUC 0- , AUMC 0-t , AUMC 0- , T 1/2 , C max and mean residence time was observed, whereas clearance (Cl) was significantly decreased in experiments involving single as well as multiple dose treatment with losartan coadministered with glimepiride + metformin